Liu J, Li J, Lin W, Shao D, et al. Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study. Int J Cancer 2022 Feb 21. doi: 10.1002/ijc.33976.
PMID: 35188268